Blood cell ratios and diabetes complications in type 2 diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study looks at how certain blood cell ratios relate to blood sugar control and blood vessel problems in people with type 2 diabetes. It helps doctors understand which patients might be at higher risk for complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with type 2 diabetes (not type 1).
- You have a recent HbA1c test result (either less than 7 or 7 or higher).
- You do not have immune thrombocytopenia, liver failure, or a blood cancer.
- You are not currently taking blood thinners, antiplatelet drugs, or steroids.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two simple blood test ratios (uric acid/HDL and monocyte/HDL) to see if they can help predict diabetes-related complications. It may give doctors a new way to catch problems early.
This study looks at how well the cells lining your blood vessels work and how the body's regenerative cells may behave in people with or without type 2 diabetes. It involves giving a blood sample and answering questions to help researchers understand blood vessel health.
This study looks at why people with type 2 diabetes develop heart problems. Researchers will examine special cells in your blood and inflammation markers to better understand these complications.
This study looks at the role of red blood cells in heart disease risk for people with type 2 diabetes. It may help us understand how to better prevent heart problems.
This trial looks at how well blood sugar is managed affects the heart's ability to pump blood in people who have both type 2 diabetes and heart disease. It may help understand if better glucose control can improve heart health.
This study looks at two blood test results—HbA1c (average blood sugar) and red blood cell width (RDW)—in people with type 2 diabetes whose blood sugar is not well controlled. The goal is to see how these two measurements relate after improving blood sugar management.
Hear when a new Vascular Complication, Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.